Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6750638 | 0.87 | KDM4E (0.36) | KDM4ETSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL6695208 | 0.82 | KDM4E (0.35) | KDM4ETSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL18560867 | 0.80 | KDM4E (0.32) | KDM4ETSHR | |
| SCHEMBL21525765 | 0.80 | KDM4E (0.32) | KDM4ETSHR | |
| SCHEMBL21525762 | 0.80 | KDM4E (0.32) | KDM4ETSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL2605525 | 0.80 | KDM4E (0.32) | KDM4ETSHR | |
| SCHEMBL18560853 | 0.80 | KDM4E (0.32) | KDM4ETSHR | |
| SCHEMBL18587310 | 0.80 | KDM4E (0.32) | KDM4ETSHR | |
| SCHEMBL11528508 | 0.80 | KDM4E (0.36) | KDM4ETSHRALDH1A1TDP1LMNA | |
| SCHEMBL6697436 | 0.80 | KDM4E (0.36) | KDM4ETSHRMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9291901-B2 | Amine treated maleic anhydride polymers with pendent silyl group, compositions and applications thereof | SUMITOMO BAKELITE CO., LTD. (JP) | 2016-03-22 | — | — | US | claimed |
| WO-2015038412-A2 | AMINE TREATED MALEIC ANHYDRIDE POLYMERS WITH PENDENT SILYL GROUP, COMPOSITIONS AND APPLICATIONS THEREOF | PROMERUS, LLC (US) | 2015-03-19 | — | — | WO | claimed |
| US-20150079507-A1 | AMINE TREATED MALEIC ANHYDRIDE POLYMERS WITH PENDENT SILYL GROUP, COMPOSITIONS AND APPLICATIONS THEREOF | PROMERUS, LLC (US) | 2015-03-19 | — | — | US | claimed |
| US-9291901-B2 | Amine treated maleic anhydride polymers with pendent silyl group, compositions and applications thereof | SUMITOMO BAKELITE CO., LTD. (JP) | 2016-03-22 | — | — | US | disclosed |
| US-20150079507-A1 | AMINE TREATED MALEIC ANHYDRIDE POLYMERS WITH PENDENT SILYL GROUP, COMPOSITIONS AND APPLICATIONS THEREOF | PROMERUS, LLC (US) | 2015-03-19 | — | — | US | disclosed |
| WO-2015038412-A2 | AMINE TREATED MALEIC ANHYDRIDE POLYMERS WITH PENDENT SILYL GROUP, COMPOSITIONS AND APPLICATIONS THEREOF | PROMERUS, LLC (US) | 2015-03-19 | — | — | WO | disclosed |
| US-6777570-B2 | Process for producing norbornene derivative having organosilyl group | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-08-17 | — | — | US | disclosed |
| US-20040063982-A1 | Process for producing norbornene derivative having organosilyl group | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063982-A1 | Process for producing norbornene derivative having organosilyl group | GRIA2, GRM2, GRM8 | KDM4E 2658/4885TSHR 1793/4885MEN1 380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.